KENDRA BRANDT: Open Payments
NPI 1013445477 · SANFORD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$239 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $167 · 2025 $239
Food & beverage: $239
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $67 |
| Galderma Laboratories, L.P. | 1 | $47 |
| Novo Nordisk Inc | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
Products named: SHINGRIX, JARDIANCE, TRELEGY ELLIPTA, NEFFY, Rybelsus, Ozempic, VAXNEUVANCE, Kerendia.
Industry payments across NC — which companies pay providers there.
